Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia:: where are we now and where do we go from here?

被引：42

作者：

Locatelli, F ^{[1
]}

Aljama, P

Barany, P

Canaud, B

Carrera, F

Eckardt, KU

Macdougall, IC

Macleod, A

Hörl, WH

Wiecek, A

Cameron, S

机构：

[1] Osped Alessandro Manzoni, Dept Nephrol & Dialysis, Div Nefrol & Dialisi, I-23900 Lecce, Italy

[2] Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain

[3] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Sci, Div Renal Med, Stockholm, Sweden

[4] Lapeyronie Univ Hosp, Dept Nephrol, Montpellier, France

[5] Hosp SAMS, Dept Nephrol & Dialysis, Lisbon, Portugal

[6] Humboldt Univ, Bereich Med Charite, Dept Nephrol & Med Intens Care, D-1040 Berlin, Germany

[7] Kings Coll Hosp London, Dept Renal Med, London, England

[8] Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen, Scotland

[9] Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria

[10] Silesian Univ, Sch Med, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland

[11] Guys St Thomas & Kings Med Sch, Dept Nephrol & Transplantat, London, England

来源：

关键词：

anaemia; antibodies; guidelines; pure red-cell aplasia; rHuEpo;

D O I：

10.1093/ndt/gfg489

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：288 / 293

页数：6

共 20 条